Award
Award #75D30126D21004
Pfizer Awarded Major Contract for Adult COVID-19 Vaccines Supply
Buyer
Centers for Disease Control and Prevention
Award Amount
$505,272,000.00
Ceiling
$505,272,000.00
Awarded
June 01, 2026
Period of Performance
Jun 01, 2026
Identifier
75D30126D21004
NAICS
325412
This award represents a significant indefinite delivery vehicle (IDV) contract granted to Pfizer Inc, a leading pharmaceutical company known for its vaccine development expertise. The contract pertains to the procurement of adult COVID-19 vaccines for fiscal years 2026 and 2027, underscoring the ongoing commitment to public health preparedness and pandemic response. The scope of work includes the delivery of vaccines in accordance with Executive Order 14398, aimed at ensuring vaccine availability. The contract was competitively awarded to Pfizer, reflecting their established capacity and prior performance in vaccine supply. This long-term agreement is substantial in scale and is set to initiate in mid-2026, marking a continuation of efforts to combat COVID-19 with effective immunization measures.
Description
FY 26-27 ADULT COVID VACCINES EO 14398